Nanda Kumar Sasi, PhD, is a Senior Scientist in Analytical Development at AstraZeneca, where they characterize genome editing tools to support engineered cell therapy products. Previously, they served as a Scientist II at Appia Bio, leading the Molecular Biology Core to optimize workflows and enhance lentiviral vector platforms. Nanda obtained a PhD in Genetics from Michigan State University after conducting research on small molecule inhibitors and high-throughput screening. Their diverse experience includes roles as a Postdoctoral Associate at The Rockefeller University and various internships in biotechnology and molecular biology.
This person is not in the org chart
This person is not in any teams
This person is not in any offices